CANTOR FITZGERALD & CO. - 30 Jun 2025 SCHEDULE 13G Report for OnKure Therapeutics Inc. Class A Common Stock, par value $0.0001 per share (OKUR)

Filing Manager
CANTOR FITZGERALD & CO.
Reporting Manager
Cantor Fitzgerald Securities
Security
OnKure Therapeutics Inc. Class A Common Stock, par value $0.0001 per share
Symbol
OKUR
Shares outstanding
12,875,750 shares
Disclosed Ownership
669,539 shares
Ownership
5.2%
Form type
SCHEDULE 13G
Filing time
14 Aug 2025, 16:05:10 UTC
Date of event
30 Jun 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"CANTOR FITZGERALD & CO. disclosed 5.2% ownership in OnKure Therapeutics Inc. Class A Common Stock, par value $0.0001 per share (OKUR) on 30 Jun 2025."

Quick Takeaways

  • CANTOR FITZGERALD & CO. filed SCHEDULE 13G for OnKure Therapeutics Inc. Class A Common Stock, par value $0.0001 per share (OKUR).
  • Disclosed ownership: 5.2%.
  • Date of event: 30 Jun 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Aug 2025, 16:05.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Cantor Fitzgerald Securities 5.2% 669,539 0 669,539 /s/ Pascal Bandelier Pascal Bandelier/Co-Chief Executive Officer
Cantor Fitzgerald & Co. 5.2% 669,539 0 669,539 /s/ Pascal Bandelier Pascal Bandelier/Co-Chief Executive Officer
Cantor Fitzgerald, L.P. 5.2% 669,539 0 669,539 /s/ Brandon Lutnick Brandon Lutnick/Chairman & Chief Executive Officer
CF Group Management, Inc. 5.2% 669,539 0 669,539 /s/ Brandon Lutnick Brandon Lutnick/Chairman & Chief Executive Officer

Sponsored